bucladesine has been researched along with Skin Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergoc, R; Cricco, G; Darvas, Z; Falus, A; Fitzsimons, C; Hegyesi, H; Kovács, P; Lázár-Molnár, E; Martin, G; Pállinger, E; Rivera, ES; Tóth, S | 1 |
| Delescluse, C; Pruniéras, M; Regnier, M | 1 |
| Cox, J; Csank-Brassert, J; Laugier, P; Orusco, M; Posternak, F; Posternak, T | 1 |
| Bath, DW; Hashimoto, K; Kanzaki, T | 1 |
| Busse, E; Riessbeck, KH; Rose, H | 1 |
| Alvero-Jackson, H; Benathan, M; Frenk, E; Mooy, AM; Scaletta, C | 1 |
| Belman, S; Troll, W | 1 |
1 review(s) available for bucladesine and Skin Neoplasms
| Article | Year |
|---|---|
The culture of skin. A review of theories and experimental methods.
Topics: Amino Acids; Animals; Bucladesine; Cytological Techniques; Depression, Chemical; DNA, Neoplasm; DNA, Viral; Humans; Mitosis; Organ Culture Techniques; Psoriasis; Skin; Skin Neoplasms | 1976 |
6 other study(ies) available for bucladesine and Skin Neoplasms
| Article | Year |
|---|---|
Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Bucladesine; Cell Division; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gene Expression; Guanidines; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Imidazoles; Interleukin-6; Isoquinolines; Melanoma; Polymerase Chain Reaction; Receptors, Interleukin-6; Skin Neoplasms; Sulfonamides; Tumor Cells, Cultured | 2002 |
[Regression of experimental tumours in mice by treatment with two cAMP analogues (author's transl)].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bucladesine; Cyclic AMP; Drug Evaluation, Preclinical; Mice; Neoplasms, Experimental; Skin Neoplasms | 1976 |
Human malignant melanoma in vivo and in vitro.
Topics: Bucladesine; Cell Differentiation; Cell Line; Cytoskeleton; Humans; Melanocytes; Melanoma; Neoplasms, Experimental; Nevus, Pigmented; Skin Neoplasms | 1977 |
Changes in mouse skin cyclic nucleotides during chemical carcinogenesis and tumor response to treatment with BCG, L-Dopa and cyclic DBAMP.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; BCG Vaccine; Bucladesine; Cyclic AMP; Levodopa; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neoplasm Recurrence, Local; Neoplasms, Experimental; Skin Neoplasms | 1979 |
Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
Topics: Bucladesine; Buthionine Sulfoximine; Cell Differentiation; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Eye Neoplasms; Glutathione; Glutathione Transferase; Humans; Kinetics; Melanins; Melanoma; Melphalan; Methionine Sulfoximine; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Staging; Skin Neoplasms; Tumor Cells, Cultured | 1992 |
Phorbol-12-myristate-13-acetate effect on cyclic adenosine 3',5'-monophosphate levels in mouse skin and inhibition of phorbol-myristate-acetate-promoted tumorigenesis by theophylline.
Topics: Alcohols; Animals; Bucladesine; Butyrates; Carcinogens; Cyclic AMP; Depression, Chemical; Dexamethasone; Dimethyl Sulfoxide; Diterpenes; Dose-Response Relationship, Drug; Fatty Acids; Female; Mice; Mitosis; Neoplasms, Experimental; Skin; Skin Neoplasms; Theophylline; Time Factors | 1974 |